A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
about
Engineering opportunities in cancer immunotherapyMultiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.CAR T-cell immunotherapy: The path from the by-road to the freeway?Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China.Design of chimeric antigen receptors with integrated controllable transient functions.Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy.Chimeric antigen receptor transduced T cells: Tuning up for the next generation.CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells.Allogeneic cell therapy manufacturing: process development technologies and facility design options.The Role of Gene Editing in Neurodegenerative Diseases.Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies
P2860
Q26776373-63B4EDEE-2EC4-4459-9913-E9E2F48708F5Q34047618-720C016B-406B-45AE-9CFF-BD9380AEE333Q38632105-F7135987-F48B-4146-860D-45F48D9C1146Q38786626-FA9924DD-1C24-44EF-BD65-906899836673Q38805082-83AE23E4-E226-4EF4-B681-AF8AB52D47D6Q39037477-346CF479-AAD5-4271-9A91-E47490972BB5Q39256918-B88B1E98-D1F0-4D5D-9775-26E923665BABQ40318331-2E57459E-122A-46F7-8FA9-6549AE5CF8BDQ46694980-062DD228-22EC-4432-A950-3977AD271FE6Q48337005-2F51E7AE-FF03-46E2-864D-22DF7BDE153BQ50036521-08DBAA6A-132C-4849-B6B6-A3208505E5A0Q50432799-9D83F746-1C3E-464C-B6B9-8C57050F1678Q55709239-5CCEA991-663F-4698-AB2B-DAEA183CEBF5Q58780007-5CFBD458-0563-4214-98C6-AFDED1A4C5F5
P2860
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@ast
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@en
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@nl
type
label
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@ast
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@en
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@nl
prefLabel
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@ast
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@en
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@nl
P2093
P2860
P356
P1433
P1476
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.
@en
P2093
Alan Marechal
Alexandre Juillerat
Aymeric Duclert
Jean-Marie Filhol
Laurent Poirot
Philippe Duchateau
Valérie Guyot
P2860
P304
P356
10.1038/MT.2015.104
P577
2015-06-10T00:00:00Z